CA19-9 is not specific to PDAC pancreatic cancer. It will reflect other GI pathologies and is documented as a marker of various inflammatory processes, whether inflammation as a result of a post-surgical procedure, respiratory tract infection, immunological response to a vaccination, etc. it is a single point in time which on its own is not of diagnostic value. A trend occurring over a period of time would then warrant further investigation to determine origination of cause.